CYTOMED THERAPEUTICS LTD (GDTC)

SGXZ17669631 - Common Stock

2.29  -0.67 (-22.64%)

After market: 2.04 -0.25 (-10.92%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-6-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
0.000.000.000.000.00
Minority Interest Expense
280.00270.000.000.000.00
Operating Expenses
3.60M3.94M2.95M1.72M1.85M
Research and Development
1.51M1.31M1.24M860.00K830.00K
Selling, General, and Administrative Expenses
2.07M2.65M680.00K660.00K250.00K
Operating Income
-3.60M-3.94M-2.95M-1.72M-1.85M
Interest Income/Expense
537.17K-190.92K-180.00K-340.00K-110.00K
Non Recurring Items
N/A0.000.0010.00K20.00K
Income Before Taxes
-3.06M-4.13M-3.13M-2.05M-1.94M
Income Tax
650.00650.000.000.000.00
Net Income
-3.06M-4.13M-3.13M-2.05M-1.94M
EBITDA
-3.26M-3.56M-2.56M-1.39M-1.56M
 
Per Share Data
EPS Diluted Total Ops
-0.27-0.39-0.27-0.19-0.18
 
Statistics

All data in SGD

Charts